NEW YORK (TheStreet) -- Shares of HCP (HCP - Get Report) were largely flat in midday trading on Monday ahead of the company's 2016 third quarter results, due out before tomorrow's opening bell.

Wall Street is forecasting that funds from operations and revenue will decline year-over-year.

Analysts surveyed by FactSet are projecting core funds from operations of 71 cents per share on revenue of $629.50 million.

During the same quarter last year, the Irvine, CA-based healthcare real estate investment trust posted funds from operations of 79 cents per diluted share on revenue of $657.95 million.

Funds from operations is a key metric in the REIT industry, which takes net income and adds back items such as depreciation and amortization.

Separately, TheStreet Ratings Team has a "Hold" rating with a score of C on the stock.

The primary factors that have impacted the rating are mixed. The company's strengths can be seen in multiple areas, such as its increase in net income, revenue growth and expanding profit margins.

But the team also finds weaknesses including disappointing return on equity and a generally disappointing performance in the stock itself.

Recently, TheStreet Ratings objectively rated this stock according to its "risk-adjusted" total return prospect over a 12-month investment horizon. Not based on the news in any given day, the rating may differ from Jim Cramer's view or that of this articles's author.

You can view the full analysis from the report here: HCP